Christina Caron

Christina Caron is a New York Times reporter based in New York, where she covers mental health. She focuses on solutions and is interested in the connection between art and mental well-being; strategies to manage stress, anxiety or anger; psychiatric medications; the mental health of teenagers; attention-deficit hyperactivity disorder; cannabis; how screens affect mental health; and suicide prevention. Caron has been a journalist for nearly two decades, but initially pursued a career in clinical research before attending the Missouri School of Journalism. She joined ABC News and NBC News before starting at The Times in 2014. In 2022, she received the National Press Foundation's Carolyn C. Mattingly award for her coverage of how Covid affected mental health in the United States, particularly among Black teenagers. As a Times journalist, Caron adheres to the standards of integrity outlined in The Times' Ethical Journalism Handbook and does not have any financial or other ties to biotech and pharmaceutical companies.

93%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

95%

Examples:

  • Escitalopram and paroxetine users were 10% to 15% more likely to gain at least 5% of their baseline weight than sertraline users.
  • Patients who took Lexapro or Paxil gained about a pound more on average than those who took Zoloft.
  • Users of escitalopram (Lexapro) and paroxetine (Seroxat) gained roughly 1 pound more than those on sertraline after six months.

Deceptions

85%

Examples:

  • The study, published on Monday in the journal Annals of Internal Medicine,

Recent Articles

New Study Reveals Which Antidepressants Are Most Likely to Cause Weight Gain

New Study Reveals Which Antidepressants Are Most Likely to Cause Weight Gain

Broke On: Monday, 01 July 2024 A recent study published in the Annals of Internal Medicine found that escitalopram and paroxetine users gained roughly 1 pound more than sertraline users after six months, with a higher likelihood of gaining at least 5% of their baseline weight. Bupropion saw the least amount of weight gain among first-line antidepressants. The study offers more detailed information on antidepressant impact on weight gain and aims to help providers and patients make informed decisions.